Boston Technology Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Boston Technology Review.

Press releases published on July 14, 2026

Jul. 14, 2026

CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB)

Indeterminate GlobeNewswire

Jul. 14, 2026

InnoCare Announces Publication in STTT (IF=81.2) of Phase 3 Results Showing Orelabrutinib Significantly Prolonged Progression-Free Survival in Treatment-Naïve CLL/SLL

Indeterminate GlobeNewswire

Jul. 14, 2026

Pure DC Launches One of Europe’s Largest Ever AI Infrastructure Projects: Phase 1 (110MW) of an over €7.5 Billion, 550MW AI Campus in Seinäjoki, Begins Fully Leased, with Planning & Power Already Secured

Indeterminate GlobeNewswire

Jul. 14, 2026

Microchip Advances Neural Network Implementation with VectorBlox™ 3.0 Accelerator SDK

Indeterminate GlobeNewswire

Jul. 14, 2026

GoCharting Introduces GoChamp: A New Standard in Trading Competitions Using CME Group Data

Indeterminate GlobeNewswire

Jul. 14, 2026

Axiom Biosciences Reports Positive Phase 1 Results for Investigational Stem Cell Therapy in Newborns with Severe Brain Injury

Indeterminate GlobeNewswire

Jul. 14, 2026

Kura Oncology to Present First Long-Term Follow-Up Data Further Supporting Darlifarnib’s Potential to Enhance VEGFR-Targeted Therapy in Renal Cell Carcinoma at KCRS 2026

Indeterminate GlobeNewswire

Jul. 14, 2026

Octave to Report Second Quarter 2026 Financial Results on August 12

Indeterminate GlobeNewswire

Jul. 14, 2026

Verano Hosting Grand Opening Celebration of MÜV Bradfordville on Friday, July 17th, Elevating the Company’s Retail Footprint to 86 Florida Dispensaries and 163 Locations Nationwide

Indeterminate GlobeNewswire

Jul. 14, 2026

Atea Pharmaceuticals Initiates First-in-Human Phase 1 Clinical Trial of AT-587 for the Treatment of Hepatitis E Virus

Indeterminate GlobeNewswire

Jul. 14, 2026

Xanadu and Lockheed Martin Expand Quantum Talent Pipeline

Indeterminate GlobeNewswire

Jul. 14, 2026

Youxin Technology Announces a US$20 Million Strategic Investment Intent and Cooperation Framework with RiverBit

Indeterminate GlobeNewswire

Jul. 14, 2026

Can-Fite Secures Australian Patent Allowance Supporting Namodenoson Development and Marketing in Liver and Pancreatic Cancer

Indeterminate GlobeNewswire

Jul. 14, 2026

Pluri Chairman Alejandro Weinstein’s Cumulative Investment Exceeds $17 Million, Ownership Surpasses 30%

Indeterminate GlobeNewswire

Jul. 14, 2026

Orezone Reports Q2 2026 Production and Provides Casa Berardi Operations Update

Indeterminate GlobeNewswire

Jul. 14, 2026

Spero Therapeutics Announces $105 Million Non-Recourse Non-Dilutive Financing Backed by a Portion of Utebzi Milestones & Royalties

Indeterminate GlobeNewswire

Jul. 14, 2026

Xebia Axis Now Available: An Agentic Data Foundation That Prepares Enterprise Data for AI

Indeterminate GlobeNewswire

Jul. 14, 2026

NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy

Indeterminate GlobeNewswire

Jul. 14, 2026

Spero Therapeutics and Innovent Biologics Announce Exclusive License for SP001 (IBI355), a Phase 2-Ready Third-Generation Anti-CD40L Antibody

Indeterminate GlobeNewswire

Jul. 14, 2026

Cliq Digital AG schließt Rückerwerbsangebot mit einem Rückerwerbsvolumen von rund EUR 5,3 Millionen ab

Indeterminate GlobeNewswire